{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:23:31Z","timestamp":1772252611845,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Although Down syndrome (DS) is the most frequent human chromosomal disorder and it causes mainly intellectual disability, its clinical presentation is complex and variable. Objective: We aimed to analyze and compare the transcriptome disruption in several brain areas from individuals with DS and euploid controls as a new approach to consider a global systemic differential disruption of gene expression beyond chromosome 21. Methods: We used data from a DNA microarray experiment with ID GSE59630 previously deposited in the GEO DataSet of NCBI database. The array contained log2 values of 17,537 human genes expressed in several aeras of the human brain. We calculated the differential gene expression (Z-ratio) of all genes. Results: We found several differences in gene expression along the DS brain transcriptome, not only in the genes located at chromosome 21 but in other chromosomes. Moreover, we registered the lowest Z-ratio correlation between the age ranks of 16\u201322 weeks of gestation and 39\u201342 years (R2 = 0.06) and the highest Z-ratio correlation between the age ranks of 30\u201339 years and 40\u201342 years (R2 = 0.89). The analysis per brain areas showed that the hippocampus and the cerebellar cortex had the most different gene expression pattern when compared to the brain as a whole. Conclusions: Our results support the hypothesis of a systemic imbalance of brain protein homeostasis, or proteostasis network of cognitive and neuroplasticity process, as new model to explain the important effect on the neurophenotype of trisomy that occur not only in the loci of chromosome 21 but also in genes located in other chromosomes.<\/jats:p>","DOI":"10.3390\/genes13040628","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:22:39Z","timestamp":1648848159000},"page":"628","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated Quantitative Neuro-Transcriptome Analysis of Several Brain Areas in Human Trisomy 21"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1369-2328","authenticated-orcid":false,"given":"Alejandra","family":"Rodr\u00edguez-Ortiz","sequence":"first","affiliation":[{"name":"SIT Consulting\u2014Science, Innovation & Technology, Cali 76001, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-7149","authenticated-orcid":false,"given":"Julio","family":"Montoya-Villegas","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology and Pathogenesis, Department of Physiological Sciences, School of Basic Sciences, Faculty of Health, Universidad del Valle, Cali 76001, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1013-0701","authenticated-orcid":false,"given":"Felipe","family":"Garc\u00eda-Vallejo","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology and Pathogenesis, Department of Physiological Sciences, School of Basic Sciences, Faculty of Health, Universidad del Valle, Cali 76001, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-1526","authenticated-orcid":false,"given":"Yecid","family":"Mina-Paz","sequence":"additional","affiliation":[{"name":"Health and Movement Research Group, Faculty of Health, Universidad Santiago de Cali, Cali 76001, Colombia"},{"name":"Faculty of Education and Sports Sciences, Escuela Nacional del Deporte, Cali 76001, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/338915","article-title":"From down syndrome to the \u201chuman\u201d in \u201chuman genetics\u201d **previously presented at the annual meeting of The American Society of Human Genetics, in San Diego, on October 15, 2001","volume":"70","author":"Epstein","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_2","first-page":"44","article-title":"Study of Down syndrome in 238,942 consecutive births","volume":"41","author":"Stoll","year":"1998","journal-title":"Ann. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/OGX.0000000000000490","article-title":"First-trimester crown-rump length and risk of chromosomal aberrations\u2014A systematic review and meta-analysis","volume":"72","author":"Peleg","year":"2017","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/pd.4792","article-title":"Down syndrome: Perinatal mortality risks with each additional week of expectant management","volume":"36","author":"Sparks","year":"2016","journal-title":"Prenat. Diagn."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1399-0004.2000.570201.x","article-title":"Down syndrome: Genetic recombination and the origin of the extra chromosome 21","volume":"57","author":"Hassold","year":"2000","journal-title":"Clin. Genet."},{"key":"ref_6","first-page":"141","article-title":"Parental origin, nondisjunction, and recom-bination of the extra chromosome 21 in Down syndrome: A study in a sample of the Colombian population","volume":"27","author":"Yunis","year":"2007","journal-title":"Biomedica"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-54299-1.00006-6","article-title":"Neurological phenotypes for Down syndrome across the life span","volume":"197","author":"Lott","year":"2012","journal-title":"Prog. Brain Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11689-010-9054-3","article-title":"Development and validation of the Arizona Cognitive Test Battery for Down syndrome","volume":"2","author":"Edgin","year":"2010","journal-title":"J. Neurodev. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Roper, R.J., and Reeves, R.H. (2006). Understanding the Basis for Down Syndrome Phenotypes. PLoS Genet., 2.","DOI":"10.1371\/journal.pgen.0020050"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1523\/JNEUROSCI.3728-10.2010","article-title":"Down syndrome: From understanding the neurobiology to therapy","volume":"30","author":"Gardiner","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down\u2019s syndrome","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-3-7091-6380-1_20","article-title":"The \u201cgene dosage effect\u201d hypothesis versus the \u201camplified developmental instability\u201d hypothesis in Down syndrome","volume":"57","author":"Pritchard","year":"1999","journal-title":"Mol. Biol. Down Syndr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/520000","article-title":"Classification of human chromosome 21 gene-expression variations in down syndrome: Impact on disease phenotypes","volume":"81","author":"Graison","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/hmg\/ddg217","article-title":"Global disruption of the cerebellar transcriptome in a Down syndrome mouse model","volume":"12","author":"Saran","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vilardell, M., Rasche, A., Thormann, A., Maschke-Dutz, E., A P\u00e9rez-Jurado, L., Lehrach, H., and Herwig, R. (2011). Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genom., 12.","DOI":"10.1186\/1471-2164-12-229"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10519-006-9053-z","article-title":"Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: Implication in Down syndrome cognitive dis-orders","volume":"36","author":"Kahlem","year":"2006","journal-title":"Behav. Genet."},{"key":"ref_17","first-page":"105","article-title":"Molecular mapping of the Down syndrome phenotype","volume":"360","author":"Korenberg","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ygeno.2007.08.005","article-title":"Gene expression profiling in the adult Down syndrome brain","volume":"90","author":"Lockstone","year":"2007","journal-title":"Genomics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/519248","article-title":"Natural gene-expression variation in down syndrome modulates the outcome of gene-dosage imbalance","volume":"81","author":"Prandini","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Volk, M., Maver, A., Lovre\u010di\u0107, L., Juvan, P., and Peterlin, B. (2013). Expression signature as a biomarker for prenatal diagnosis of trisomy 21. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074184"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1590\/1414-431X20143792","article-title":"Bioinformatics analysis of biomarkers and transcriptional factor motifs in Down syndrome","volume":"47","author":"Kong","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3892\/etm.2016.3462","article-title":"Co-expression network analysis of Down\u2019s syndrome based on microarray data","volume":"12","author":"Zhao","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01422-6","article-title":"Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature13200","article-title":"Domains of genome-wide gene expression dysregulation in Down\u2019s syndrome","volume":"508","author":"Letourneau","year":"2014","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"eLife"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrg.2016.154","article-title":"Down syndrome and the complexity of genome dosage imbalance","volume":"18","author":"Antonarakis","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2016.01.042","article-title":"Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination","volume":"89","author":"Kang","year":"2016","journal-title":"Neuron"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1525-1578(10)60455-2","article-title":"Analysis of Microarray Data Using Z Score Transformation","volume":"5","author":"Cheadle","year":"2003","journal-title":"J. Mol. Diagn."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-biochem-060614-033955","article-title":"The Biology of Proteostasis in Aging and Disease","volume":"84","author":"Labbadia","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1101\/gr.1951304","article-title":"Transcript Level Alterations Reflect Gene Dosage Effects Across Multiple Tissues in a Mouse Model of Down Syndrome","volume":"14","author":"Kahlem","year":"2004","journal-title":"Genome Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2217\/epi-2016-0138","article-title":"Trans-acting epigenetic effects of chromosomal aneuploidies: Lessons from Down syndrome and mouse models","volume":"9","author":"Do","year":"2017","journal-title":"Epigenomics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/15592294.2016.1192736","article-title":"Epigenetic dysregulation in the developing Down syndrome cortex","volume":"11","author":"Dittrich","year":"2016","journal-title":"Epigenetics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.08.014","article-title":"Mitochondria as pharmacological targets in Down syndrome","volume":"114","author":"Valenti","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.bbadis.2013.04.013","article-title":"Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer\u2019s disease neuropathology: Redox proteomics analysis of human brain","volume":"1832","author":"Coccia","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Aivazids, S., Coughlan, C.M., Rauniyar, A.K., Jiang, H., Liggett, L.A., MacLean, K.N., and Roede, J.R. (2017). The burden of trisomy 21 disrupts the proteostasis network in Down syndrome. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176307"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Li, C.M., Guo, M., Salas, M., Schupf, N., Silverman, W., Zigman, W.B., Husain, S., Warburton, D., Thaker, H., and Tycko, B. (2006). Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med. Genet., 7.","DOI":"10.1186\/1471-2350-7-24"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4614-0653-2_22","article-title":"Oxidative Stress and Mitochondrial Dysfunction in Down Syndrome","volume":"724","author":"Pagano","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in down syndrome: Molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00018-009-0123-2","article-title":"Function and regulation of Dyrk1A: Towards understanding down syndrome","volume":"66","author":"Park","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1096\/fj.12-213124","article-title":"Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis","volume":"27","author":"Wu","year":"2013","journal-title":"FASEB J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/hmg\/dds529","article-title":"Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects","volume":"22","author":"Piccoli","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3233\/JAD-2011-111172","article-title":"Overexpression of Amyloid-\u03b2 Protein Precursor Induces Mitochondrial Oxidative Stress and Activates the Intrinsic Apoptotic Cascade","volume":"28","author":"Bartley","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/4\/628\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:48:21Z","timestamp":1760136501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/4\/628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["genes13040628"],"URL":"https:\/\/doi.org\/10.3390\/genes13040628","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-745690\/v1","asserted-by":"object"}]},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}